Show filters
Resources type
Filter by Resources type
Filter by Pathologies
Filter by Technologies
Filter by Instruments
25 result(s) found
Sort by:

Sebia and Metafora biosystems form strategic partnership to develop advanced in vitro diagnostics

Press Release
Sep. 16, 2021

Sebia to acquire a minority stake in Metafora biosystems.

Hemoglobinopathy Testing: What are the Key Points a Lab Should Consider?

Sep. 08, 2021

Educational Webinar Dr. Cornelia L. Harteveld from Leiden University Medical Center

Performance of Immunotyping vs. Immunofixation for the Detection of Monoclonal Gammopathies

Sep. 08, 2021

Educational Webinar with Katie Thoren, PhD, Memorial Sloan Kettering Cancer Center

Multiple Myeloma clinical cases at diagnosis and monitoring according to latest IMWG recommendations

Aug. 30, 2021

Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD

Experience and recommendations of a Major Cancer Center to use HYDRASHIFT daratumumab

Aug. 09, 2021

Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.

HbA1c – The Hidden Factors

Jul. 15, 2021

HbA1c is routinely used in the clinical laboratory to diagnose and monitor diabetes mellitus. Many methods have been standardized to provide precise and accurate results for normal patients. For the other common Hb variants, most of the methods are now relatively free of analytical interference.